Skip to main content
Mary Dinauer, MD, Pediatric Hematology & Oncology, Saint Louis, MO

MaryCDinauerMD

Pediatric Hematology & Oncology Saint Louis, MO

Professor, Pediatrics, Washington University School of Medicine

Are you Dr. Dinauer?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 57 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

  • Office

    1 Childrens Pl
    Div Ped Hematology Onc Ste 9S
    Saint Louis, MO 63110
    Phone+1 314-454-6018
    Fax+1 844-621-4392
  • Is this information wrong?

Summary

  • Dr. Mary Dinauer, MD is a pediatric hematologist/oncologist in Saint Louis, Missouri. She is currently licensed to practice medicine in Missouri, Indiana, and California. She is a Professor at Washington University School of Medicine.

Education & Training

  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1985 - 1989
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Pediatrics, 1981 - 1985
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1981

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1983 - Present
  • MO State Medical License
    MO State Medical License 2012 - 2024
  • IN State Medical License
    IN State Medical License 1991 - 2011
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1995

Publications & Presentations

PubMed

Press Mentions

  • Tumor Selective Uptake of Drug-Nanodiamond Complexes Improves Therapeutic Outcome in Pancreatic Cancer
    Tumor Selective Uptake of Drug-Nanodiamond Complexes Improves Therapeutic Outcome in Pancreatic CancerMay 8th, 2019

Grant Support

  • Gene Therapy Of X-Linked Chronic Granulomatous DiseaseNational Heart, Lung, And Blood Institute1995–2009
  • Gene Replacement Therapy In Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute1995–2009
  • Structure/Function Analysis Of Phagocyte ProteinsNational Heart, Lung, And Blood Institute1991–2009
  • 2005 Phagocytes Gordon ConferenceNational Institute Of Allergy And Infectious Diseases2005
  • AdministrativeNational Heart, Lung, And Blood Institute2005
  • Core C- Administrative CoreNational Heart, Lung, And Blood Institute2004
  • Regulation Of Phagocyte Function By RAC2National Heart, Lung, And Blood Institute2002
  • Gene Therapy Of X-Linked Chronic Granulomatous DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1998
  • Murine Model Of X Linked Chronic Granulomatous DiseaseNational Heart, Lung, And Blood Institute1994–1998
  • Structure-Function Analysis Of Phagocyte ProteinsNational Heart, Lung, And Blood Institute1994–1995
  • Molecular Studies Of Phagocyte Oxidase B-CytochromeNational Heart, Lung, And Blood Institute1992–1993
  • Structure/Function Analysis Of Phagocyte ProteinsNational Heart, Lung, And Blood Institute1991
  • Molecular Studies Of Phagocyte Oxidase B-CytochromeNational Heart, Lung, And Blood Institute1989–1991